| Date | Time | Source | Headline | Symbol | Company |
| 02/01/2024 | 8:00AM | PR Newswire (US) | Evofem Biosciences Announces Strong Preliminary Results, Record Phexxi Net Sales for Fiscal 2023 | NASDAQ:ADTX | Aditxt Inc |
| 01/30/2024 | 5:28PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:ADTX | Aditxt Inc |
| 01/30/2024 | 4:30PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:ADTX | Aditxt Inc |
| 01/30/2024 | 8:30AM | Business Wire | Aditxt, Inc. Acquires Proprietary Electroencephalography (EEG) Brain Monitoring Technologies and Devices, Including NeuroCap™ and NeuroEEG™ for Telehealth and Tele-neurology Applications | NASDAQ:ADTX | Aditxt Inc |
| 01/23/2024 | 4:18PM | Edgar (US Regulatory) | Form D - Notice of Exempt Offering of Securities | NASDAQ:ADTX | Aditxt Inc |
| 01/19/2024 | 4:15PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:ADTX | Aditxt Inc |
| 01/18/2024 | 4:30PM | Edgar (US Regulatory) | Form S-1 - General form for registration of securities under the Securities Act of 1933 | NASDAQ:ADTX | Aditxt Inc |
| 01/09/2024 | 5:19PM | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business combinations | NASDAQ:ADTX | Aditxt Inc |
| 01/09/2024 | 5:16PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:ADTX | Aditxt Inc |
| 01/08/2024 | 8:30AM | Business Wire | Aditxt, Inc.’s Subsidiary Pearsanta, Inc. Acquires MDNA Life Sciences Inc.’s Proprietary Mitomic™ Testing Platform Pioneering Early Disease and Cancer Detection in a Transaction Valued at Approximately $25 Million | NASDAQ:ADTX | Aditxt Inc |
| 01/05/2024 | 4:30PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:ADTX | Aditxt Inc |
| 01/05/2024 | 8:45AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:ADTX | Aditxt Inc |
| 01/05/2024 | 8:30AM | Business Wire | Aditxt Announces Closing of $6.0 Million Private Placement Priced At-The-Market under Nasdaq Rules | NASDAQ:ADTX | Aditxt Inc |
| 01/02/2024 | 8:45AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:ADTX | Aditxt Inc |
| 01/02/2024 | 8:30AM | Business Wire | Aditxt, Inc. Regains Compliance with Nasdaq Stockholders’ Equity Requirement | NASDAQ:ADTX | Aditxt Inc |
| 12/29/2023 | 5:07PM | Business Wire | Aditxt Announces $6 Million Private Placement Priced At-The-Market under Nasdaq Rules | NASDAQ:ADTX | Aditxt Inc |
| 12/26/2023 | 5:26PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:ADTX | Aditxt Inc |
| 12/22/2023 | 5:00PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:ADTX | Aditxt Inc |
| 12/22/2023 | 4:30PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:ADTX | Aditxt Inc |
| 12/21/2023 | 4:30PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:ADTX | Aditxt Inc |
| 12/12/2023 | 5:09PM | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business combinations | NASDAQ:ADTX | Aditxt Inc |
| 12/12/2023 | 5:04PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:ADTX | Aditxt Inc |
| 12/12/2023 | 8:30AM | Business Wire | Aditxt, Inc. Enters into Definitive Agreement to Acquire Evofem Biosciences, Inc., Creator of Phexxi®, the First and Only FDA-Approved Hormone-Free Contraceptive Gel, to Address Diverse Reproductive Health Needs of Women Globally | NASDAQ:ADTX | Aditxt Inc |
| 12/08/2023 | 4:05PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:ADTX | Aditxt Inc |
| 12/01/2023 | 4:39PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:ADTX | Aditxt Inc |
| 11/16/2023 | 4:30PM | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] | NASDAQ:ADTX | Aditxt Inc |
| 11/16/2023 | 12:15AM | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | NASDAQ:ADTX | Aditxt Inc |
| 11/13/2023 | 4:30PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ADTX | Aditxt Inc |
| 11/13/2023 | 4:30PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ADTX | Aditxt Inc |
| 11/13/2023 | 4:30PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ADTX | Aditxt Inc |